Everyone should have a right to know more about themselves, we make it possible!

Welcome

The DNA Labs team is incredibly happy to welcome you to our new updated Web Site and invite you to learn more about us, as we join with you, together in pursuit of great health and wellbeing.

We like to say, it is in our DNA, our unrelenting passion of creativity and imagination, unstoppable in our quest for developing useful, affordable, and practical genetic designed for everyone.

Our team cares deeply about helping the people we serve, our customers, our professionals, and stakeholders. The DNA Labs team prides itself on being genuine, authentic, and collaborative. We seek to succeed and travel on roads not yet built believing that the best ideas are always in front of us. Rest assured that the ethical values and high standards we hold dear will only be matched by trustworthiness and integrity in everything we do.

Dr. Aaron Goldman, PhD

Chief Science Officer

An expert in cutting edge genomic technologies, Dr. Goldman brings more than 20 years of experience in life sciences including his PhD in Molecular Genetics from Yale University and post-doctoral studies at the University of Toronto.

Meet Aaron

As Chief Science Officer at DNALabs, Aaron oversees all aspects of genetic test design, interpretation and implementation, as well as providing scientific and technical support to marketing and business/strategic planning initiatives.

Prior to his work at DNALabs, Dr. Goldman was the Director of Genomics Services at the University Health Network/Mount Sinai Hospital Clinical Genomics Centre in Toronto, a state-of-the-art, full service genomics technology facility that provides genomics services such as DNA sequencing and genotyping to the research community. In parallel, Dr. Goldman also served as the Research Program Director and co-founder of Mt. Sinai Hospital’s Office of Personalized Genomics and Innovative Medicine, which was established to facilitate the implementation of genomic discoveries into routine medical practice, and to ultimately improve the speed and precision of disease diagnostics and the quality of patient care. In his roles at Mount Sinai Hospital, Dr. Goldman was instrumental in successfully managing several large research programs which attracted over $10 million of funding from various governmental organizations.

If you’re in medicine, healthcare and/or wellness then it’s time you became better informed about what this rapid pace of growth in genetic testing and genome discovery might mean to your stakeholders and all health consumers.

We are fascinated by the future and what lies ahead.

Our own DNA is personal and tells a story about ourselves. What we know about ourselves can help make better choices in how we live our lives.

It’s the beginning of personalized medicine.

New era in medicine

DNALabs is a Canadian owned genetics company that is committed to providing genetic testing solutions to help everyone know more about themselves. Our DNA holds critical and unique information about us, including how we interact with medicine. With a simple cheek swab, healthcare practitioners can now personalize treatment options that are best suited for each of us.

Genetic testing

The role of genetic testing in medicine is expanding. Why? Because of the impact and benefits in the prevention, management and treatment of various diseases.

Genetic testing is the tool to delivering personalized medicine.

Real scientific breakthroughs

The science behind the over 70,000 genetic tests in the North American market right now is sound. In fact, the breakthroughs and new additional tests are entering the market daily.

DNALabs is here to help you.

DNALabs Executive Team

DNALabs is solely dedicated to the new frontier of genome laboratory testing and the transformation to personalized medicine with developing affordable and cutting-edge genetic testing products.

We are proud to be forward thinking and agile. This is reflected most dramatically with the corporate structure and our leadership team with their portfolios. This is a non-hierarchical organization. The company is committed to remaining at the forefront of pharmacogenomics including breakthrough applications of DNA testing to health and wellness. The lack of silos in the organization is reflected in more than its organizational chart. It is a business philosophy and commitment to agility and entrepreneurial spirit. It is a promise to ensure the company is responsive to market opportunities and at the forefront of science and technology advances that create market demand, such as our cannabis sensitivity testing. We strive to create best in class products at affordable prices that simply differentiate themselves in today’s world. Most importantly we are mindful of the trust and expectations our customers, suppliers and stakeholders have put in us as we continue to build a foundation for transformational change.